#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13878	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2042	670.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	781	C	738	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3786	663.8	0	.	n	.	0	T695C	SNP	695	695	T	1083	1083	C	746	C	709	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3786	663.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1725	1725	A	816	A,G	762,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3786	663.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2359	2359	C	773	C	729	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3786	663.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2433	2433	A	797	A	753	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25296	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3786	663.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2985	2985	C	816	C	773	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2014	folP	852	852	100.0	folP.l6.c30.ctg.1	1517	131.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1047	1049	AGC	219;216;216	A;G;C	204;204;204	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5088	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3177	158.1	1	SNP	p	S91F	0	.	.	271	273	TCC	470	472	TCC	167;164;165	T;C;C	157;157;158	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5088	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3177	158.1	1	SNP	p	D95G	0	.	.	283	285	GAC	482	484	GAC	162;159;159	G;A;C	157;153;152	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5088	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3177	158.1	1	SNP	p	D95N	0	.	.	283	285	GAC	482	484	GAC	162;159;159	G;A;C	157;153;152	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1430	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1346	105.0	0	.	p	.	0	A39T	NONSYN	115	117	GCC	520	522	ACC	206;204;206	A;C,A;C	188;188,1;191	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1430	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1346	105.0	0	.	p	.	0	R44H	NONSYN	130	132	CGC	535	537	CAC	200;202;207	C;A;C	185;189;196	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1430	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1346	105.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	718	720	CAC	188;188;189	C;A;C	173;173;174	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1430	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1346	105.0	1	SNP	p	G45D	0	.	.	133	135	GGC	538	540	GGC	208;212;212	G;G;C	196;199;197	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	802	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1030	77.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5124	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2825	179.4	1	SNP	p	D86N	0	.	.	256	258	GAC	511	513	GAC	212;215;214	G;A;C	200;200;201	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5124	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2825	179.4	1	SNP	p	S87R	0	.	.	259	261	AGT	514	516	AGT	216;211;208	A;G;T	201;200;193	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5124	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2825	179.4	1	SNP	p	S87I	0	.	.	259	261	AGT	514	516	AGT	216;211;208	A;G;T	201;200;193	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5124	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2825	179.4	1	SNP	p	S87W	0	.	.	259	261	AGT	514	516	AGT	216;211;208	A;G;T	201;200;193	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5124	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2825	179.4	1	SNP	p	S88P	0	.	.	262	264	TCC	517	519	TCC	206;208;209	T;C;C	192;195;196	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4194	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2647	156.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1546	1548	GGC	190;188;185	G;G;C	181;177;174	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1298	1300	GCA	194;193;192	G;C;A	182;183;186	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1301	1303	ATC	195;197;199	A;T;C	188;191;191	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1313	1315	GTG	203;201;204	G;T;G	194;191;194	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1313	1315	GTG	203;201;204	G;T;G	194;191;194	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1817	1819	ACC	225;223;219	A,T;C;C	207,1;209;205	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1871	1873	GCG	205;204;205	G;C;G	181;164;171	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1871	1873	GCG	205;204;205	G;C;G	181;164;171	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1994	1996	GGC	172;172;174	G;G;C	161;159;161	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2003	2005	GGC	168;166;166	G;G;C	151;149;151	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3870	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2532	151.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2021	2023	CCG	156;156;156	C;C;GCCC,GGCCCC	133;132;128,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5298	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3164	166.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1709	1711	CTG	181;181;184	C,A;T;G	168,1;167;174	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2262	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1895	118.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	532	532	C	182	C	165	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2458	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1546	157.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	409	411	GGA	214;214;213	G;G;A	200;200;197	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2458	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1546	157.5	0	.	p	.	0	F135L	NONSYN	403	405	TTT	670	672	CTT	210;211;208	C;T;T	197;198;195	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2458	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1546	157.5	0	.	p	.	0	R143G	NONSYN	427	429	AGA	694	696	GGA	198;195;195	G;G;A	182;184;182	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2458	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1546	157.5	0	.	p	.	0	D171G	NONSYN	511	513	GAT	778	780	GGT	191;188;189	G;G,T;T	176;175,1;175	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2458	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1546	157.5	0	.	p	.	0	G189S	NONSYN	565	567	GGC	832	834	AGC	188;187;186	A;G;C	180;179;177	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2458	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1546	157.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	898	898	T	180	T	172	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2458	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1546	157.5	1	SNP	p	G120K	0	.	.	358	360	GGT	625	627	GGT	221;219;219	G;G;T	201;202;199	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2458	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1546	157.5	1	SNP	p	A121N	0	.	.	361	363	GCC	628	630	GCC	219;219;222	G;C;C	203;203;208	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2458	porB1b	1035	1035	95.82	porB1b.l6.c4.ctg.1	1546	157.5	1	SNP	p	A121D	0	.	.	361	363	GCC	628	630	GCC	219;219;222	G;C;C	203;203;208	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9862	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	5031	194.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2149	2151	AAT	204;201;201	A;A;T	192;188;190	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1044	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1092	95.3	1	SNP	p	V57M	1	.	.	169	171	ATG	550	552	ATG	201;201;202	A;T;G	189;189;191	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
